I am going to take a deep dive into Redx Pharma Plc’s (LON:REDX) most recent ownership structure, not a frequent subject of discussion among individual investors. Ownership structure of a company has ...

It ain’t over ‘til it’s over and for Redx Pharma, it’s over. Redx and Jounce Therapeutics announced Monday morning that the two companies agreed to terminate their proposed business combination ...

A $425 million proposed marriage between Redx Pharma of the UK and Jounce Therapeutics is on the rocks, just over a month after it was first announced. Jounce has instead thrown its lot in with ...

Jazz Pharmaceuticals has struck a deal to source two targeted cancer therapies from Redx Pharma. Redx will pocket $10 million upfront, with more to follow, in return for developing candidates against ...

ALDERLEY PARK, United Kingdom and CAMBRIDGE, Mass., Feb. 23, 2023 (GLOBE NEWSWIRE) -- Redx Pharma (AIM: REDX) and Jounce Therapeutics, Inc. (Nasdaq: JNCE) today announce an unanimously recommended ...

Sam Waksal’s attempt to buy Redx Pharma has fallen apart. The failure of a company set up by the once-jailed biotech executive to close a deal led Redx to turn to Redmile for the cash to keep going ...

Shares in Redx Pharma were under pressure today following the announcement that it would not be advancing its cancer drug candidate RXC004 into phase 3 testing in biliary tract cancer, after it failed ...

There’s significant change on the way at Jounce Therapeutics. The embattled clinical-stage company announced Wednesday afternoon that it is laying off more than half of its workforce as part of a ...

Redx Pharma PLC CEO Lisa Anson joins Proactive's Stephen Gunnion with details of a landmark partnership with Jazz Pharmaceuticals, marking its largest deal to date. Anson explained the agreement ...

(Reuters) -British biotech firm Redx Pharma plc and U.S.-based Jounce Therapeutics Inc will merge to create a $425 million entity specialised in treating cancer and fibrotic disease. Redx shareholders ...